Steris insider trading
Health Care · Heavy sellingShare price and insider trades
Valuation, profit and volume
Summary
Over the past 12 months, 0 Steris insiders reported open-market purchases totaling $0, while 7 insiders reported sales totaling $9.9M. 4 of 13 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 51 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 12SEC | Mohsen SohiDirector | Sell | 4,058 | $235.78 | $957K | -10.5% | — |
| Jun 16SEC | John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | Sell Plan | 1,419 | $209.28 | $297K | +0.9% | — |
| Jun 8SEC | Daniel A CarestioCEO, President | Sell Plan | 3,054 | $214.64 | $656K | -1.7% | — |
| Jun 8SEC | Daniel A CarestioCEO, President | Sell Plan | 1,374 | $212.00 | $291K | -0.4% | — |
| Jun 4SEC | Richard C BreedenDirector | Sell | 1,481 | $209.51 | $310K | +0.7% | — |
| Mar 6SEC | Cynthia L FeldmannDirector | Sell | 3,098 | $237.21 | $735K | -11.0% | — |
| Nov 25SEC | Julia MadsenSr. Vp And Gm, Life Sciences | Sell | 2,872 | $262.00 | $752K | -19.4% | — |
| Nov 25SEC | Julia MadsenSr. Vp And Gm, Life Sciences | Sell | 2,136 | $262.00 | $560K | -19.4% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 3,324 | $257.43 | $856K | -18.0% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 1,500 | $257.76 | $387K | -18.1% | — |
| Nov 20SEC | Renato TamaroV.P. & Corporate Treasurer | Sell | 212 | $258.03 | $55K | -18.2% | — |
| Nov 13SEC | John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | Sell | 15,000 | $265.14 | $4.0M | -20.4% | — |
| Oct 8SEC | Daniel A CarestioCEO, President | Sell Plan | 159 | $241.82 | $38K | -12.7% | — |
Insiders at Steris
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| John Adam ZangerleSr. Vp, Gen Counsel, And Sec. | — | $4.3M | Jun 16, 2026 | — |
| Julia MadsenSr. Vp And Gm, Life Sciences | — | $1.3M | Jun 8, 2026 | — |
| Renato TamaroV.P. & Corporate Treasurer | — | $1.3M | Jun 8, 2026 | — |
| Daniel A CarestioCEO, President | — | $985K | Jun 8, 2026 | — |
| Mohsen SohiDirector | — | $957K | Aug 12, 2026 | — |
| Cynthia L FeldmannDirector | — | $735K | Mar 6, 2026 | — |
| Richard C BreedenDirector | — | $310K | Jun 4, 2026 | — |
| Mary Clare FraserSvp & Chief Hro | — | — | Jun 8, 2026 | — |
| Kenneth E KohlerSvp & Gm, Ast | — | — | Jun 8, 2026 | — |
| Karen L BurtonCFO | — | — | Jun 8, 2026 | — |
| Lindsey McgowanVp, Chf. Comp. & Quality Offc. | — | — | Jun 4, 2026 | — |
| Cary L MajorsPresident | — | — | Jun 4, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about STE insiders
Are Steris insiders buying STE stock?
In the past 12 months, 0 insiders reported open-market purchases of STE worth $0.
Are Steris insiders selling STE stock?
7 insiders reported sales worth $9.9M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.